Turning lipids research into new drugs
A lipid (fat) whose anti-inflammatory activities were discovered by Cardiff University, with colleagues from Universities of Pittsburgh, Oregon and Michigan, is being developed into a new drug for the treatment of diseases that currently have limited therapeutic options.
Cleveland Clinic Researchers Find Beta Blockers Have Positive Effect in Pulmonary Arterial Hypertension
A team of Cleveland Clinic researchers found that a common heart disease medication, beta blockers, may help treat pulmonary arterial hypertension (PAH), a debilitating lung disease.
Combination of Biomarkers Identified That Predicts Disease Progression in IPH
The ratio between the proteins MMP2 and TIMP4 in blood samples of idiopathic pulmonary arterial hypertension (iPAH) patients was found to predict disease worsening and mortality in a German study.
Holistic Approach Helps Patients Engage in Care
Recent advances and clinical research have shown that better care for people with pulmonary arterial hypertension (PAH) can lead to longer lives. But recently the focus has shifted from treatment options that improve the functional aspects of the disease alone to including care that improves overall quality of life and the ability to perform day-to-day activities. A review published in the European Respiratory Review (…
Adcirca Shown Effective for Pediatric Patients with PAH in Clinical Practice in Japan
Adcirca (tadalafil) showed an acceptable safety profile and effectiveness in a real-world clinical cohort of pediatric patients with pulmonary arterial hypertension (PAH) in Japan.
Doctors Are Doing Inadequate Job of Screening Scleroderma Patients for PAH, Study Concludes
Scientists have long known that people with scleroderma are at increased risk of developing pulmonary arterial hypertension. But many with scleroderma whom doctors suspect of having PAH are not receiving optimal screening for the respiratory condition, a study concludes. Nor are enough scleroderma patients suspected of having pulmonary hypertension being referred for tests that would confirm the condition.
Breathing in a New Gene Therapy to treat Pulmonary Hypertension
Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the lungs that is linked to heart failure. If the therapy succeeds in human clinical trials, it will provide patients for the first time with a way to reverse the damage caused by PH
Anges Québec leads $us 9 million financing round for innovative medical technology
Anges Québec announced a major investment in 4C Medical Technologies Inc., a company developing minimally invasive therapies for structural heart disease.
Positive Interim Results Of Aironite Phase 2 Study Presented At 4th Annual Drug Discovery And Development Symposium For Pulmonary Hypertension
Aironite Significantly Lowered Pulmonary Artery Pressures and Significantly Increased Pulmonary Arterial Compliance
Teenage girl undergoes first combined heart-lung transplant
Giving a big leap to organ transplant surgeries in the two Telugu States, Yashoda Hospitals, Secunderabad, performed the first-ever combined heart-lung transplantation surgery on a single person simultaneously.
Recent News


Get the latest on PH treatments, community events and more when you subscribe to our newsletter